Emeramide for Mercury Toxicity

About EmeraMed

EmeraMed is a private, clinical-stage biotech developing Emeramide, a unique dithiol compound with antioxidant and metal-chelating properties. Its primary focus is on obtaining marketing authorization for treating mercury toxicity, supported by completed Phase 2 trials demonstrating safety. The company is also exploring applications in other conditions like COPD and COVID-19, where oxidative stress and iron dysregulation play a role, though these are in earlier stages of investigation.

Therapeutic Areas